首页 正文

Diffuse large B-cell lymphoma: what clinical progress have we seen in the last 5 years?

{{output}}
Introduction: Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma and has a rapidly evolving treatment landscape. For patients at increased risk of primary treatment failure and those with relapsed/re... ...